DNA Sequencing Services Market Size, Share & Analysis | 2031
DNA Sequencing Services Market Size, Share & Analysis | 2031
Segments - DNA Sequencing Services Market Report by Type (Next Generation Sequencing [Whole Genome Sequencing, Targeted Sequencing, and Whole Exome Sequencing], Sanger Sequencing, and Third Generation DNA Sequencing), Application (Oncology, Reproductive Health, Clinical Investigation, Consumer Genomics, HLA Typing, and Others), End-User (Hospitals, Diagnostic Centers, Clinical Research, Academic Research, and Research Institutes), and Region (Asia Pacific, North America, Latin America, Europe, and Middle East & Africa) - Global Share, Growth, Size, Global Industry Analysis, Trends, and Forecast 2023 – 2031
Upcoming
| Report ID :HC-5539
| 4.8 Rating
| 68 Reviews
| 184 Pages
| Format :
Report Description
The global DNA sequencing services market size was valued at USD 9.65 Billion in 2022 and is likely to reach USD 35.42 Billion by 2031, expanding at a CAGR of 14.4% during the forecast period, 2023–2031. The market growth is attributed to the growing adoption of whole-genome sequencing for diagnostic purposes.
The rapid surge in the adoption of whole genome sequencing by several research and health institutes is expected to fuel the demand for DNA sequencing services as it provides detailed and precise data for identifying outbreaks sooner. It allows researchers and practitioners to characterize bacteria and detect genetic disorders in unborn children.
Whole-genome sequencing is a comprehensive method for analyzing entire genomes. Scientists use whole genome sequencing to decipher the genetic material found in an organism or virus.
-
For instance, on March 17, 2022, the National Health of Institute research program released the first genomic dataset of nearly 100,000 whole genome sequences to address unanswerable questions about health and disease, leading to new discoveries.
DNA Sequencing is the process of identifying the order of four bases in a strand of DNA. The order of strand bases are adenine, guanine, cytosine, and thymine. It is a highly accurate and high-throughput process. DNA sequencing allows healthcare practitioners to determine if a gene contains variants or mutations, linked to a disorder.
Sequencing is utilized in molecular biology to study genomes and the proteins encoded. Insight from sequencing allows researchers to identify noncoding DNA, associated with diseases and phenotypes, and identify potential drug targets.
Impact of Artificial Intelligence on DNA Sequencing Services Market
DNA sequencing coupled with artificial intelligence is a lucrative opportunity in the market. The application of AI algorithms is utilized to analyze and interpret genetic data obtained from different sources, including gene expression profiling and DNA sequencing. The AI algorithm is used to process complex and large genomic datasets.
It offers researchers or scientists to identify genetic mutations, predict drug responses, and the disease causes. AI-powered DNA sequencing gains a deeper insight into the genetic mechanisms underlying health and disease, leading to the development of new therapies and drugs.
- For instance, on June 9, 2023, Oxford Nanopore Technologies plc partnered with Geneyx, an AI platform to develop the first scalable software solution for the end-to-end analysis and clinical reporting of nanopore sequencing data.
The COVID-19 pandemic propelled the market. The demand for DNA sequencing increased to identify the virus spread. DNA sequencing helped vaccine manufacturers and public health official researchers by offering critical evidence related to the COVID-19 virus. World Health Organization (WHO) recommended that nations need to speed up genome sequencing and share genomic data and findings in a coordinated way, which further boosted the market.
-
For instance, in April 2020, the Government of the UK formed the COVID-19 Genomics UK Consortium (COG-UK) to collect, sequence, and analyze SARS-CoV-2 genomes to understand viral transmission and evolution. Similarly, on December 30, 2020, INSACOG was formed by the Government of India with IMCR and CSIR to sequence and monitor SARS-CoV-2 genomic variations.
DNA Sequencing Services Market Dynamics
Major Drivers
Increasing prevalence of cancer is projected to drive the market. DNA sequencing technology is used in the diagnosis of cancer as it allows doctors and oncologists to identify specific cancer types and provide effective treatment. For instance, on February 3, 2022, WHO published a report stating that cancer is the leading cause of death worldwide, accounting for 10 million deaths in 2020 or nearly 1 in 6 deaths.
The growing adoption of precision medicine is anticipated to drive the market. DNA sequencing is used in precision medicine to draw information regarding the disease and its risk by separating people into groups. It offers personalized diagnostics, disease risk assessment, and treatment selection. Major hospitals and research institutes are working to expand the branch of precision medicine.
-
For instance, on August 12, 2022, Mount Sinai, a hospital chain in New York, partnered with Regeneron Genetic Centre and launched genetic sequencing project to enhance precision medicine research.
Existing Restraints
The high capital investment cost of advanced instruments is restricting market growth. Despite of declining cost of sequencing hospitals, academic institutes, and research institutes are unable to avail of the latest instrument owing to budget constraints. Furthermore, whole genome sequencing generates data on a large scale, which requires additional storage devices and takes more time to analyze, resulting in hindering the market.
Emerging Opportunities
Increasing adoption of agricultural genomics creates lucrative opportunities in the market as DNA sequencing is utilized in agricultural genomics to enhance crop breeding, develop sustainable farming practices, and improve livestock health. Moreover, rising technological advancements in next-generation technology is an immense opportunity in the market. Next-generation sequencing technology determines the order of nucleotides in the entire DNA and provides ultra-high scalability and speed.
Scope of DNA Sequencing Services Market Report
The market report includes an assessment of the trends, market, segments, and regional markets. Overview and dynamics have also been included in the report.
|
Attributes |
Details |
|
Report Title |
DNA Sequencing Services Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast |
|
Base Year |
2022 |
|
Historic Data |
2016–2021 |
|
Forecast Period |
2023–2031 |
|
Segmentation |
Type (Next Generation Sequencing [ Whole Genome Sequencing, Targeted Sequencing, and Whole Exome Sequencing], Sanger Sequencing, and Third Generation DNA Sequencing), Application (Oncology, Reproductive Health, Clinical Investigation, Consumer Genomics, HLA Typing, and Others), and End-User (Hospitals, Diagnostic Centers, Clinical Research, Academic Research, and Research Institutes) |
|
Regional Scope |
Asia Pacific, North America, Latin America, Europe, and Middle East & Africa |
|
Report Coverage |
Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, Market Trends, and Revenue Forecast |
|
Key Players Covered in the Report |
PierianDx; Eurofins Scientific; BGI; Bio-Rad Laboratories, Inc.; Myriad Genetics, Inc.; PerkinElmer Inc.; Macrogen, Inc.; Illumina, Inc.; QIAGEN; Thermo Fisher Scientific Inc.; 23andMe, Inc.; Helix OpCo, LLC; Human Longevity, Inc.; and Guardant Health. |
DNA Sequencing Services Market Segment Insights
Type Segment Analysis
Based on product, the DNA sequencing services market is divided into next-generation sequencing, sanger sequencing, and third-generation DNA sequencing. The next-generation sequencing segment held a large market share in 2022, owing to its low cost, high scalability, and accuracy.
The growing prevalence of cancer is projected to propel segment growth as next generation sequencing allows clinicians to test many genes of cancer simultaneously and detect rare and novel cancer mutations to provide a molecular rationale for appropriate targeted therapy. Additionally, companies are developing new technologies and applications for next-generation sequencing.
- For instance, on November 3, 2022, DNASTAR announced the release of Lasergene 17.4. Lasergene is aided with new functionality to focus on variant analysis for multiple sequence alignments, including Sanger and next-generation sequencing analysis.
Third-generation DNA sequencing is anticipated to grow at a significant pace during the forecast period due to its ability to detect DNA modification without the aforementioned assay. Moreover, it offers single-molecule real-time sequencing of longer reads.
This type of sequencing does not require polymerase chain reaction (PCR) amplification and includes easy sample preparation for efficiency. Furthermore, it detects repetitive sites of complex genomes by producing lengthy reads longer than several kilobases.
Application Segment Analysis
On the basis of application, the global market is segregated into oncology, reproductive health, clinical investigation, consumer genomics, HLA typing, and others. The oncology segment held a large market share in 2022 and is expected to expand at a considerable CAGR during the assessment period, owing to the increasing prevalence of cancer across the globe as DNA sequencing helps oncologists in identifying the type and severity of cancer.
- For instance, as per the National Library of Medicine, 26 million new cancer cases and 17 million cancer deaths are estimated per year by 2030.
The consumer genomics segment is projected to grow at a rapid pace during the projected period due to its potential benefit to provide information such as disease risk, health, and other symptoms of individuals without the approval of healthcare providers or health insurance companies. It allows individuals to take preventive measures to lessen the risk of disease.
End-User Segment Analysis
In terms of end-user, the DNA sequencing services market is categorized into hospitals, diagnostic centers, clinical research, academic research, and research institutes. The clinical research segment accounted for a large market share in 2022 and is anticipated to grow at a quick pace in coming years owing to the rising number of clinical research centers and increasing investment in R&D activities. Moreover, the rising demand for precision medicine and the increasing number of alliances between leading companies and clinical research institutes is to propel the segment growth.
The research institutes are expected to witness a high CAGR growth over the projected period due to the wide adoption of DNA sequencing to gain genetic information. Scientists and researchers use sequence information to determine, which stretches of DNA contain genes. Moreover, sequence data help researchers to highlight changes in a gene, which may cause disease.
Regional Analysis
Based on region, the global market is classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. North America dominated the market in 2022 and is projected to register a considerable CAGR in the coming years, due to the ongoing research for drug development. Moreover, the presence of established healthcare infrastructure and research institutes is projected to boost market growth.
The market in Asia Pacific is estimated to witness quick growth during the forecast period, due to the high prevalence of chronic diseases, increasing investment in drug discovery, and ongoing research on genome sequencing techniques. Moreover, increasing healthcare spending by the government is expected to drive the market.
-
For instance, the Indian government intends to expand public health spending by 2.5% of country’s GDP by 2025.
Segments
The DNA sequencing services market has been segmented on the basis of
Type
- Next Generation Sequencing
- Whole Genome Sequencing
- Targeted Sequencing
- Whole Exome Sequencing
- Sanger Sequencing
- Third Generation DNA Sequencing
Application
- Oncology
- Reproductive Health
- Clinical Investigation
- Consumer Genomics
- HLA Typing
- Others
End-user
- Hospitals
- Diagnostic Centers
- Clinical Research
- Academic Research
- Research Institutes
Region
- Asia Pacific
- North America
- Latin America
- Europe
- Middle East & Africa.
Key Players
- PierianDx
- Eurofins Scientific
- BGI
- Bio-Rad Laboratories, Inc
- Myriad Genetics, Inc
- PerkinElmer Inc
- Macrogen, Inc
- Illumina, Inc
- QIAGEN
- Thermo Fisher Scientific Inc
- 23andMe, Inc
- Helix OpCo, LLC
- Human Longevity, Inc
- Guardant Health
Competitive Landscape
Key players competing in the global market are PierianDx; Eurofins Scientific; BGI; Bio-Rad Laboratories, Inc.; Myriad Genetics, Inc.; PerkinElmer Inc.; Macrogen, Inc.; Illumina, Inc.; QIAGEN; Thermo Fisher Scientific Inc.; 23andMe, Inc.; Helix OpCo, LLC; Human Longevity, Inc.; and Guardant Health.
These companies adopted development strategies including collaboration, product launches, mergers, acquisitions, partnerships, and production expansion to expand their consumer base worldwide. For instance,
-
On September 20, 2022, Pierian entered into a collaboration with Genome Medical to optimize and streamline genomic testing programs for healthcare organizations and provider groups.
-
On July 11, 2021, Qiagen entered into a strategic alliance with Sysmex Corporation for the development and commercialization of cancer companion diagnostics through next-generation sequencing.
-
On December 28, 2020, Eurofins Genomic launched SARS-CoV-2, a full-length viral genome sequencing service essential in the identification of viral mutation.
Table Of Content
1. Executive Summary2. Assumptions and Acronyms Used
3. Research Methodology
4. DNA Sequencing Services Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. DNA Sequencing Services Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. DNA Sequencing Services Market - Supply Chain
4.5. Global DNA Sequencing Services Market Forecast
4.5.1. DNA Sequencing Services Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. DNA Sequencing Services Market Size (000’ Units) and Y-o-Y Growth
4.5.3. DNA Sequencing Services Market Absolute $ Opportunity
5. Global DNA Sequencing Services Market Analysis and Forecast by Types
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Types
5.2.2. Y-o-Y Growth Projections by Types
5.3. DNA Sequencing Services Market Size and Volume Forecast by Types
5.3.1. Next Generation Sequencing
5.3.2. Sanger Sequencing
5.3.3. Third Generation DNA Sequencing
5.4. Absolute $ Opportunity Assessment by Types
5.5. Market Attractiveness/Growth Potential Analysis by Types
6. Global DNA Sequencing Services Market Analysis and Forecast by Applications
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Applications
6.2.2. Y-o-Y Growth Projections by Applications
6.3. DNA Sequencing Services Market Size and Volume Forecast by Applications
6.3.1. Oncology
6.3.2. Reproductive Health
6.3.3. Clinical Investigation
6.3.4. Consumer Genomics
6.3.5. HLA Typing
6.3.6. Others
6.4. Absolute $ Opportunity Assessment by Applications
6.5. Market Attractiveness/Growth Potential Analysis by Applications
7. Global DNA Sequencing Services Market Analysis and Forecast by End Users
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by End Users
7.2.2. Y-o-Y Growth Projections by End Users
7.3. DNA Sequencing Services Market Size and Volume Forecast by End Users
7.3.1. Hospitals
7.3.2. Diagnostic Centers
7.3.3. Clinical Research
7.3.4. Academic Research
7.3.5. Research Institutes
7.4. Absolute $ Opportunity Assessment by End Users
7.5. Market Attractiveness/Growth Potential Analysis by End Users
8. Global DNA Sequencing Services Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. DNA Sequencing Services Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global DNA Sequencing Services Demand Share Forecast, 2019-2026
9. North America DNA Sequencing Services Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America DNA Sequencing Services Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America DNA Sequencing Services Market Size and Volume Forecast by Types
9.4.1. Next Generation Sequencing
9.4.2. Sanger Sequencing
9.4.3. Third Generation DNA Sequencing
9.5. Basis Point Share (BPS) Analysis by Types
9.6. Y-o-Y Growth Projections by Types
9.7. North America DNA Sequencing Services Market Size and Volume Forecast by Applications
9.7.1. Oncology
9.7.2. Reproductive Health
9.7.3. Clinical Investigation
9.7.4. Consumer Genomics
9.7.5. HLA Typing
9.7.6. Others
9.8. Basis Point Share (BPS) Analysis by Applications
9.9. Y-o-Y Growth Projections by Applications
9.10. North America DNA Sequencing Services Market Size and Volume Forecast by End Users
9.10.1. Hospitals
9.10.2. Diagnostic Centers
9.10.3. Clinical Research
9.10.4. Academic Research
9.10.5. Research Institutes
9.11. Basis Point Share (BPS) Analysis by End Users
9.12. Y-o-Y Growth Projections by End Users
9.13. Market Attractiveness/Growth Potential Analysis
9.13.1. By Country
9.13.2. By Product Type
9.13.3. By Application
9.14. North America DNA Sequencing Services Demand Share Forecast, 2019-2026
10. Latin America DNA Sequencing Services Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America DNA Sequencing Services Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America DNA Sequencing Services Market Size and Volume Forecast by Types
10.4.1. Next Generation Sequencing
10.4.2. Sanger Sequencing
10.4.3. Third Generation DNA Sequencing
10.5. Basis Point Share (BPS) Analysis by Types
10.6. Y-o-Y Growth Projections by Types
10.7. Latin America DNA Sequencing Services Market Size and Volume Forecast by Applications
10.7.1. Oncology
10.7.2. Reproductive Health
10.7.3. Clinical Investigation
10.7.4. Consumer Genomics
10.7.5. HLA Typing
10.7.6. Others
10.8. Basis Point Share (BPS) Analysis by Applications
10.9. Y-o-Y Growth Projections by Applications
10.10. Latin America DNA Sequencing Services Market Size and Volume Forecast by End Users
10.10.1. Hospitals
10.10.2. Diagnostic Centers
10.10.3. Clinical Research
10.10.4. Academic Research
10.10.5. Research Institutes
10.11. Basis Point Share (BPS) Analysis by End Users
10.12. Y-o-Y Growth Projections by End Users
10.13. Market Attractiveness/Growth Potential Analysis
10.13.1. By Country
10.13.2. By Product Type
10.13.3. By Application
10.14. Latin America DNA Sequencing Services Demand Share Forecast, 2019-2026
11. Europe DNA Sequencing Services Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe DNA Sequencing Services Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe DNA Sequencing Services Market Size and Volume Forecast by Types
11.4.1. Next Generation Sequencing
11.4.2. Sanger Sequencing
11.4.3. Third Generation DNA Sequencing
11.5. Basis Point Share (BPS) Analysis by Types
11.6. Y-o-Y Growth Projections by Types
11.7. Europe DNA Sequencing Services Market Size and Volume Forecast by Applications
11.7.1. Oncology
11.7.2. Reproductive Health
11.7.3. Clinical Investigation
11.7.4. Consumer Genomics
11.7.5. HLA Typing
11.7.6. Others
11.8. Basis Point Share (BPS) Analysis by Applications
11.9. Y-o-Y Growth Projections by Applications
11.10. Europe DNA Sequencing Services Market Size and Volume Forecast by End Users
11.10.1. Hospitals
11.10.2. Diagnostic Centers
11.10.3. Clinical Research
11.10.4. Academic Research
11.10.5. Research Institutes
11.11. Basis Point Share (BPS) Analysis by End Users
11.12. Y-o-Y Growth Projections by End Users
11.13. Market Attractiveness/Growth Potential Analysis
11.13.1. By Country
11.13.2. By Product Type
11.13.3. By Application
11.14. Europe DNA Sequencing Services Demand Share Forecast, 2019-2026
12. Asia Pacific DNA Sequencing Services Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific DNA Sequencing Services Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific DNA Sequencing Services Market Size and Volume Forecast by Types
12.4.1. Next Generation Sequencing
12.4.2. Sanger Sequencing
12.4.3. Third Generation DNA Sequencing
12.5. Basis Point Share (BPS) Analysis by Types
12.6. Y-o-Y Growth Projections by Types
12.7. Asia Pacific DNA Sequencing Services Market Size and Volume Forecast by Applications
12.7.1. Oncology
12.7.2. Reproductive Health
12.7.3. Clinical Investigation
12.7.4. Consumer Genomics
12.7.5. HLA Typing
12.7.6. Others
12.8. Basis Point Share (BPS) Analysis by Applications
12.9. Y-o-Y Growth Projections by Applications
12.10. Asia Pacific DNA Sequencing Services Market Size and Volume Forecast by End Users
12.10.1. Hospitals
12.10.2. Diagnostic Centers
12.10.3. Clinical Research
12.10.4. Academic Research
12.10.5. Research Institutes
12.11. Basis Point Share (BPS) Analysis by End Users
12.12. Y-o-Y Growth Projections by End Users
12.13. Market Attractiveness/Growth Potential Analysis
12.13.1. By Country
12.13.2. By Product Type
12.13.3. By Application
12.14. Asia Pacific DNA Sequencing Services Demand Share Forecast, 2019-2026
13. Middle East & Africa DNA Sequencing Services Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Middle East & Africa Average Pricing Analysis
13.2. Middle East & Africa DNA Sequencing Services Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa DNA Sequencing Services Market Size and Volume Forecast by Types
13.4.1. Next Generation Sequencing
13.4.2. Sanger Sequencing
13.4.3. Third Generation DNA Sequencing
13.5. Basis Point Share (BPS) Analysis by Types
13.6. Y-o-Y Growth Projections by Types
13.7. Middle East & Africa DNA Sequencing Services Market Size and Volume Forecast by Applications
13.7.1. Oncology
13.7.2. Reproductive Health
13.7.3. Clinical Investigation
13.7.4. Consumer Genomics
13.7.5. HLA Typing
13.7.6. Others
13.8. Basis Point Share (BPS) Analysis by Applications
13.9. Y-o-Y Growth Projections by Applications
13.10. Middle East & Africa DNA Sequencing Services Market Size and Volume Forecast by End Users
13.10.1. Hospitals
13.10.2. Diagnostic Centers
13.10.3. Clinical Research
13.10.4. Academic Research
13.10.5. Research Institutes
13.11. Basis Point Share (BPS) Analysis by End Users
13.12. Y-o-Y Growth Projections by End Users
13.13. Market Attractiveness/Growth Potential Analysis
13.13.1. By Country
13.13.2. By Product Type
13.13.3. By Application
13.14. Middle East & Africa DNA Sequencing Services Demand Share Forecast, 2019-2026
14. Competition Landscape
14.1. Global DNA Sequencing Services Market: Market Share Analysis
14.2. DNA Sequencing Services Distributors and Customers
14.3. DNA Sequencing Services Market: Competitive Dashboard
14.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
14.4.1. PierianDx
14.4.2. Eurofins Scientific
14.4.3. BGI
14.4.4. Bio-Rad Laboratories, Inc
14.4.5. Myriad Genetics, Inc
14.4.6. PerkinElmer Inc
14.4.7. Macrogen, Inc
14.4.8. Illumina, Inc
14.4.9. QIAGEN
14.4.10. Thermo Fisher Scientific Inc
14.4.11. 23andMe, Inc
14.4.12. Helix OpCo, LLC
14.4.13. Human Longevity, Inc
14.4.14. Guardant Health
Methodology
Related Reports
Some other reports from this category!
Our Clients
